TGF-β1 Genotype and Breast Cancer Survival
Author Information
Author(s): Lina Mu, Dimitrios Katsaros, Ling Lu, Maria Preti, Alessandro Durando, Roberto Arisio, Herbert Yu
Primary Institution: Yale University School of Medicine
Hypothesis
The study aims to analyze the TGF-β1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival.
Conclusion
The study suggests that TGF-β1 may play a complex role in breast cancer progression, with different effects depending on the disease stage.
Supporting Evidence
- Patients with the T/T genotype had a higher risk of breast cancer death.
- High TGF-β1 levels were associated with poor survival in early-stage disease.
- The TGF-β1 genotype's effect on survival varied by disease stage.
- Patients with late-stage disease showed a lower risk of recurrence with the T/T genotype.
Takeaway
This study looked at how a specific gene related to a protein called TGF-β1 affects breast cancer survival, finding that it can have different effects depending on how advanced the cancer is.
Methodology
Fresh tumor samples were collected from 348 breast cancer patients, and TGF-β1 genotype and phenotype were analyzed using TaqMan® and ELISA methods.
Potential Biases
Potential biases may arise from the selection of patients and the retrospective nature of the study.
Limitations
The study's findings may not be generalizable to all populations due to the specific demographic of the sample.
Participant Demographics
Patients who underwent surgery for breast cancer at the University of Turin in Italy between January 1998 and July 1999.
Statistical Information
P-Value
0.013
Confidence Interval
95% CI: 1.21–10.40
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website